Accessibility settings

This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (762) Innovations and Technology in Cancer Care (592) Clinical Cancer Research (139) Cancer and Clinical Trials (54) Lung Cancer (78) Research Infrastructures and Registries (85)

Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/57183, first published .
Lucent logo with lungs and a surgeon at a computer

Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT)

Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT)

Authors of this article:

Luca Bertolaccini1 Author Orcid Image ;   Oriana Ciani2 Author Orcid Image ;   Marco Lucchi3 Author Orcid Image ;   Francesco Zaraca4 Author Orcid Image ;   Alessandro Bertani5 Author Orcid Image ;   Roberto Crisci6 Author Orcid Image ;   Lorenzo Spaggiari1, 7 Author Orcid Image ;   LUCENT Study Group8
Article Authors Cited by (3) Tweetations Metrics

Journals

  1. Bertolaccini L, Santucci C, La Vecchia C, Toffolutti F, Corso G, Spaggiari L, Serraino D. Diverging trends in lung cancer: a 26-year analysis of sex-specific patterns and histological shifts in Northern Italy. European Journal of Cancer Prevention 2025;34(5):475 View
  2. Bertolaccini L, Lombardi M, Chiari M, Rappa A, Casiraghi M, D’Ercole M, Mazzella A, Lo Iacono G, Mohamed S, Midolo De Luca V, Fusco N, Guerini Rocco E, Spaggiari L. Concordance of Actionable Driver Alterations Between Primary Lung Adenocarcinoma and Paired Thoracic Metastases: A Prospective Next-Generation Sequencing Study. Cancers 2026;18(11):1773 View

Books/Policy Documents

  1. Charan S, Masih G, Singh R, Singh A, Soroy B, Kumar U, Pal D, Medhi B. Epigenetic Therapy by Phytochemicals in Lung Cancer. View